This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine
Yi Li, Xia Mao, Mengyuan Li, Li Li, Xiwen Tong, Lifang Huang

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related gene regulation · Epigenetics and DNA Methylation · Protein Degradation and Inhibitors
Retraction Note: Clinical Epigenetics (2024) 16:16 10.1186/s13148-024-01627-9
The Editor-in-Chief has retracted this article at the request of the corresponding author Lifang Huang because the authors did not have permission to publish the data reported. Lifang Huang, Yi Li and Xwen Tong agree with this retraction. Xia Mao, Mengyuan Li and Li Li have not responded to correspondence from the Publisher about this retraction.
